Tetra Bio-Pharma Inc.
Rank 67
About
Tetra works with drug regulators to conduct cannabinoid-based research and development. Through several subsidiaries and clinical trial programmes, they aim to combine traditional medicinal cannabis with scientific validation. The North America-based company also has a patent (PPP001) for devices aimed at reducing drug abuse and treating chronic pain.
$0.1596
USD
-2.44%
Market cap
$33,819,634
Total volume
$47,581
Shares outstanding
211,969,411
Rank 67
About
Tetra works with drug regulators to conduct cannabinoid-based research and development. Through several subsidiaries and clinical trial programmes, they aim to combine traditional medicinal cannabis with scientific validation. The North America-based company also has a patent (PPP001) for devices aimed at reducing drug abuse and treating chronic pain.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
TBP |
$32,974
|
69.3% |
$0.1596
|
| TBPMF |
Total volume
$14,607
|
30.7% |
Stock price
$0.1539
|
Chart